| Sandra Menard, RPH | |
|
39 Cadoret Dr, Cumberland, RI 02864-3401 | |
| (401) 641-7034 | |
| Not Available |
| Full Name | Sandra Menard |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 39 Cadoret Dr, Cumberland, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447856539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3434 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Menard, RPH 1842 Concordia Lake Cir Unit 1102, Cape Coral, FL 33909-9063 Ph: () - | Sandra Menard, RPH 39 Cadoret Dr, Cumberland, RI 02864-3401 Ph: (401) 641-7034 |
News Archive
Women in Egypt are seeking out doctors' opinions on whether they should circumcise their daughters and, though it is illegal there, physicians are not discouraging the practice, giving legitimacy to a procedure that has serious medical risks, according to a new study led by a former Stanford University School of Medicine researcher.
A team of scientists from Sweden and India has recently conducted a study to evaluate type I interferon (IFN-I) responses in cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings reveal that SARS-CoV-2 infection is associated with a delayed and dysregulated IFN-I response and that pretreatment with IFN-I can reduce the risk of SARS-CoV-2 infection.
St. Jude Children's Research Hospital molecular biologists have identified an enzyme that activates and "supercharges" cellular machinery that controls how cells become specialized cells in the body.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
› Verified 2 days ago
Maria L Lewis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2125 Diamond Hill Rd, Cumberland, RI 02864 Phone: 401-335-4563 | |
Michael J Scampoli, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Highland Corporate Dr Ste 200, Cumberland, RI 02864 Phone: 866-799-5830 | |
Susan M Trigo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 Broad St, Cumberland, RI 02864 Phone: 401-726-8110 Fax: 401-729-8097 | |
Miss Kelsey Madison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Highland Corporate Dr, Cumberland, RI 02864 Phone: 800-746-7287 | |
Emily M Dabrosca, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1998 Mendon Rd, Cumberland, RI 02864 Phone: 401-333-1225 | |
Zachary Hopkins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2136 Mendon Rd, Cumberland, RI 02864 Phone: 401-333-1220 | |
Dr. John Tyler Hoolahan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1998 Mendon Rd, Cumberland, RI 02864 Phone: 401-333-1225 |